164788 - Urology Update for GPs
- : Online
This seminar has been developed with a GP focus to address some of the challenges that GPs face and provide practical ways to manage urological disease. It will include discussion on the latest recommendations on PSA, MRI and Biopsy detection. Newest treatments in BPH, and imaging the stone and options for prostate cancer therapy in Penrith.Relevance to General Practice
Benign prostatic hyperplasia (BPH) is the most common benign tumour in men. Although men with BPH often need medical or surgical management from a urologist, most men are initially assessed and managed by a general practitioner (GP) in the primary healthcare setting.
Prostate cancer accounts for the second highest number of male cancer deaths in Australia. With an understanding of the guidelines for prostate cancer screening and Prostate Specific Antigen (PSA) testing, GPs will be able to determine what test, for who and when.
Over 2000 cases of bladder cancer are diagnosed in Australia each year. Bladder cancer is a relatively common disease with high morbidity if left untreated. Early detection and referral allows for more treatment options.
References: AFP, Volume 40, No.4, April 2011 Pages 209-213
AJGP, Volume 47, No. 7, July 2018.